🟢 Lipocine is trading 8.81% up in pre-market; catalyst unclear

Lipocine is trading at $2.45, up +8.81% in pre-market, with no clear catalyst identified.

• On September 10, 2026, management announced it will present at the H.C. Wainwright Global Investment Conference on September 16.
• This was the only fresh company-specific item identified, and available coverage does not explicitly link it to the move.
• Broader markets were weaker; volume and activity-level data were unavailable.